Report: FDA needs to fix post-market drug safety
11646
The U.S. Food and Drug   Administration needs more staff, funding and power over the   drug industry to better police the safety of medicines after   they reach the market, an Institute of Medicine panel said on   Friday.
231875
The US Food and Drug Administration (news - web sites) on Friday asked an outside group to review the way the agency monitors safety risks of medicines after they hit the market, such as Merck &amp; Co.
145921
With the stunning recall of a popular pain medication last week and the impact it had on patients, the stock market and its manufacturer, it may be worthwhile to review how drugs get to market and how safety data are gathered.
368741
As expected, FDA officials on Friday announced plans to improve the procedures used by the agency to monitor the safety of medications after they reach the market, the Newark Star-Ledger reports.
10518
About two-thirds of Food and Drug Administration scientists are less than fully confident in the agency&#39;s monitoring of the safety of prescription
462803
Description: Faced with a series of major lapses in drug safety, the Food and Drug Administration announces new measures to rectify the situation.
90104
A report to be released on Friday finds the U.S. Food and Drug Administration does very little to ensure the safety of patients who help test drugs in clinical trials, The New York Times reports.
404541
The report is likely to intensify a debate about the safety of the nationÂs drug supply and the adequacy of government oversight.
250853
Federal drug regulators are "virtually incapable of protecting America" from unsafe drugs, a federal drug safety reviewer told a Congressional panel.
265006
U.S. lawmakers and health officials  are moving to give more independence to an office that reviews  drug safety, but some experts say ensuring medicines are  studied after they hit the market is more important than the  bureaucratic pecking order.
149596
The federal Food and Drug Administration said Friday that it would strengthen its safety and review process for pharmaceuticals already on the market to learn more about their possible side effects.
25982
An internal survey found that about two-thirds of FDA scientists lack confidence in the agency&#39;s monitoring of the safety of prescription drugs now on the market.
368795
The U.S. Food and Drug Administration on Friday asked an outside group to review the way the agency monitors safety risks of medicines after they hit the market, such as Merck & Co. Inc.'s withdrawn painkiller Vioxx.
6720
Americans are exposed to dangerous medicines because drug makers do not adequately disclose side effects and regulators are failing to react fast enough to safety risks, according to a prominent medical journal.
611669
WASHINGTON/NEW YORK  - A U.S. Food and Drug  Administration reviewer who has accused the agency of being lax  in monitoring drug safety on Thursday said five medicines on  the market need closer scrutiny.
137276
ROCKVILLE, Md.  - The U.S. Food and Drug  Administration on Friday asked an outside group to review the  way the agency monitors safety risks of medicines after they  hit the market, such as Merck & Co. Inc.'s withdrawn painkiller  Vioxx.
420242
A previously unpublished internal survey of Food and Drug Administration scientists points to potentially dangerous gaps in the approval and marketing of prescription drugs, according to documents jointly released today by the Union of Concerned